Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe – Padovanews padovanews.it - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from padovanews.it Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Cordis, a global cardiovascular technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the S.M.A.R.T..
/PRNewswire/ Cordis, a global cardiovascular technology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the S.M.A.R.T..
Share this article
Share this article
NEW YORK, May 12, 2021 /PRNewswire/ The global peripheral vascular stents market by product (Self-expanding, balloon-expanding, and drug-eluting), geography (North America, Europe, Asia, and ROW), and end-user (hospitals, ASCs, and cath labs) has been added to Technavio s offering. The global peripheral vascular stents market is expected to grow by USD 1.22 billion, at a CAGR of almost 8% during 2020-2024.
Technavio has announced its latest market research report titled Peripheral Vascular Stents Market by Product, End-user, and Geography - Forecast and Analysis 2020-2024
The market witnessed a certain decline in the production volume of peripheral vascular stents in 2020 due to the rapid spread of COVID-19. The pandemic hampered the production capacity of vendors, which impeded market growth. However, the increasing adoption of MI angioplasty procedures and the expansion of the global geriatric population are expected to foster market grow